Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Otlertuzumab
Trade Name
Synonyms TRU-016|TRU016|TRU 016
Drug Descriptions

Otlertuzumab (TRU-016) is a anti-CD37 therapeutic protein, which may result in increased antibody-dependent cellular cytotoxicity and decreased tumor cell growth (PMID: 24381226, PMID: 25146490, PMID: 27977057).

DrugClasses CD37 Antibody 8
CAS Registry Number 1372645-37-8
NCIT ID C74006


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bendamustine + Otlertuzumab Bendamustine Otlertuzumab 0 1
Ibrutinib + Otlertuzumab Ibrutinib Otlertuzumab 0 1
Idelalisib + Otlertuzumab + Rituximab Idelalisib Otlertuzumab Rituximab 0 1
Obinutuzumab + Otlertuzumab Obinutuzumab Otlertuzumab 0 1
Otlertuzumab Otlertuzumab 0 0
Otlertuzumab + Rituximab Otlertuzumab Rituximab 0 1

Additional content available in CKB BOOST